With a strong focus on characterizing molecular interactions exactly as they occur in the human body, our team provides customers with biologically relevant information to improve efficiency and performance of pharmaceutical drug development. Attanas technology can also help customers to validate candidates in crude samples and serum.
Attana’s third generation biosensors are today used to determine specificity, kinetics and affinity -among other binding characteristics- of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Our technology has been validated by academic institutions, biotech companies and big-pharma across the world.
We are headquartered in Stockholm, Sweden.
Get in touch for a more detailed discussion, contact us.
After 15 years of continuous development and improvements, our third generation biosensor understands the complex world of cell interactions.
Attana’s system can not only unravel biochemical pathways between (bio)molecules but can also shed light on (bio)molecules – cell interactions, determine off-target interactions and perform assays with crude samples and in sera, providing in that way a wealth of biologically relevant information.